July 23, 2010 - Elemental Impurities in Pharmaceutical Ingredients and Products

PSG Pharmafocus recently published an article in their July 2010 issue, where Dr. Stephen Jenkins, Actlabs' R&D manager for the Pharmaceutical department, discusses upcoming changes to the USP <231> for heavy metals testing that will focus on ICP OES and ICP MS analytical techniques. Click here to see the article.

Activation Laboratories Ltd.
Search | Privacy | Contact Us | News RSS | Login